R&D PIPELINE

Jinyang Pharm produces high-quality products through strict quality control.
  • CATEGORY
  • CLASSIFICATION
  • PRODUCT
  • PROOF OF CONCEPT
  • FORMULATION STUDY
  • STABILITY TEST
  • CLINICAL STUDY / BE STUDY
  • REGISTRATION
IMD SGLT2 Inhibitors JY302
※ We are currently conducting clinical trials for a new diabetes complex.
DPP-4 Inhibitors JY404
Cough & Cold remedies Sobnal A Tab.
Generic H+ Pump Inhibitors Eszol Tab.
Antilipidemic Agents Atovzet Tab. Jintozet Tab.
Antihypertensives Amvaltan Tab.
Antihypertensives Temistar Tab.
SGLT2 Inhibitors JY301
DPP-4 Inhibitors JY401
DPP-4 Inhibitors JY402
DPP-4 Inhibitors JY403
P-CAB JY501
Written date: March 2022